New Key Statistics Module, Z-Score and F-Score
NAS:ICPT Key Ratios
| Market Cap $ M | 559.21 |
| Enterprise Value $ M | 406.32 |
| P/E(ttm) | 2.07 |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 5.99 |
| Price/Sales | 1.41 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 2.30 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 315.00 |
| EPS (TTM) $ | 6.47 |
| Beneish M-Score | 0.38 |
| 10-y EBITDA Growth Rate % | -0.20 |
| 5-y EBITDA Growth Rate % | 23.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.92 |
| EV-to-EBITDA | -2.93 |
| PEG | -- |
| Shares Outstanding M | 41.67 |
| Net Margin (%) | 70.39 |
| Operating Margin % | -16.43 |
| Pre-tax Margin (%) | -50.36 |
| Quick Ratio | 2.35 |
| Current Ratio | 2.35 |
| ROA % (ttm) | 41.98 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | -49.36 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.26 |
| Piotroski F-Score | 5.00 |
| Positive ROA | Y |
| Positive CFROA | N |
| Higher ROA y-y | Y |
| Cash flow > Earnings | N |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | Y |
ICPT Number of Guru Trades
ICPT Volume of Guru Trades
Gurus Latest Trades with NAS:ICPT
NAS:ICPT is held by these investors
No Available Data
Intercept Pharmaceuticals Inc Insider Transactions
Total 0
Total 0
News about NAS:ICPT
Total 0- 1
